Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
05/03/20246:05AMPR Newswire (Canada)Cipher Pharmaceuticals Schedules Q1 2024 Earnings Release and Conference CallTSX:CPHCipher Pharmaceuticals Inc
05/03/20246:05AMPR Newswire (US)Narxoz University announces an agreement with Queen's University Belfast for a branch at the Almaty campus, with signing ceremony attended by Lord Cameron
05/03/20246:05AMPR Newswire (US)AtmosFX Reveals All 2024 New Decoration Collections in a Variety Show
05/03/20246:05AMPR Newswire (US)MycoWorks Welcomes Ginevra Boralevi to Leadership Team as Communications Executive
05/03/20246:05AMPR Newswire (US)Hershey Declares Quarterly DividendsNYSE:HSYHershey Company
05/03/20246:04AMPR Newswire (US)Now Leasing: The Grand at Market District Offers Contemporary Rental Living in Statesboro
05/03/20246:04AMPR Newswire (US)ParkMobile is the Official Parking Reservation Provider for the Cleveland Guardians at Progressive Field
05/03/20246:03AMPR Newswire (US)Summer House's West Wilson Helps Rehab Monster and Five Iron Golf Tea Off New Partnership
05/03/20246:03AMPR Newswire (US)Take some time to breathe in May by improving your indoor air quality
05/03/20246:00AMPR Newswire (Canada)Pour éviter la grève, MDA Espace doit débloquer la négociation
05/03/20246:00AMPR Newswire (Canada)MTY FOOD GROUP INC. ANNOUNCES RESULTS FROM 2024 ANNUAL GENERAL MEETINGTSX:MTYMTY Food Group Inc
05/03/20246:00AMPR Newswire (US)Clayton® Unveils First Encore Home at 2024 Berkshire Hathaway Annual Shareholders Meeting
05/03/20246:00AMPR Newswire (Canada)/R E P R I S E -- INVITATION AUX MÉDIAS : ANNONCE CONCERNANT LE LOGEMENT SOCIAL ET ABORDABLE À SAINTE JULIE/
05/03/20246:00AMPR Newswire (Canada)Fisheries and Oceans Canada investigates the causes of the increase in sedimentation at Grande-Entrée, in the Magdalen Islands
05/03/20246:00AMPR Newswire (Canada)/R E P E A T -- MEDIA ADVISORY - HOUSING ANNOUNCEMENT IN TERREBONNE/
05/03/20246:00AMPR Newswire (Canada)Ouragan Fiona : DEC a accordé plus de 7,6 M$ en appui aux sinistrés de la Gaspésie et des Îles‑de‑la‑Madeleine
05/03/20246:00AMPR Newswire (Canada)Pêches et Océans Canada étudie les causes à l'origine d'une sédimentation accrue à Grande-Entrée aux Îles-de-la-Madeleine
05/03/20246:00AMPR Newswire (Canada)AVIS DE CONVOCATION AUX MÉDIAS - Dévoilement des lauréats du concours Les Mercuriades 2024
05/03/20246:00AMPR Newswire (Canada)/R E P R I S E -- INVITATION AUX MÉDIAS - Conférence de presse concernant le développement du secteur des pêches aux Îles-de-la-Madeleine/
05/03/20246:00AMPR Newswire (Canada)/R E P R I S E --Invitation aux médias - Annonce concernant la lutte contre l'exploitation sexuelle des enfants sur Internet/
05/03/20246:00AMPR Newswire (Canada)GROUPE D'ALIMENTATION MTY INC. PUBLIE LE RÉSULTAT DU VOTE DE SES ACTIONNAIRES TENU LORS DE SON ASSEMBLÉE GÉNÉRALE ANNUELLE 2024TSX:MTYMTY Food Group Inc
05/03/20246:00AMPR Newswire (Canada)/R E P R I S E -- AVIS AUX MÉDIAS - ANNONCE CONCERNANT LE LOGEMENT À TERREBONNE/
05/03/20246:00AMPR Newswire (Canada)CareRx Corporation to Host First Quarter 2024 Financial Results Conference Call on Friday, May 10, 2024 at 8:30 a.m. ETTSX:CRRXCareRX Corporation
05/03/20246:00AMPR Newswire (Canada)Avis aux médias - Itinéraire du premier ministre pour le vendredi 3 mai 2024
05/03/20246:00AMPR Newswire (Canada)/R E P R I S E -- INVITATION AUX MÉDIAS : ANNONCE D'UN PROJET D'HABITATION NOVATEUR À TERREBONNE/
05/03/20246:00AMPR Newswire (Canada)Hurricane Fiona: CED has granted over $7.6M in aid to disaster victims in Gaspésie and Les Îles‑de‑la‑Madeleine
05/03/20246:00AMPR Newswire (Canada)Media Advisory - Prime Minister's itinerary for Friday, May 3, 2024
05/03/20246:00AMPR Newswire (US)Industry Leaders Tint World® and XPEL Announce Partnership
05/03/20246:00AMPR Newswire (Canada)CPE : les travailleuses affiliées à la CSN amorcent leur négociation
05/03/20246:00AMPR Newswire (US)HanAll Biopharma Announces Initiation of Phase III Randomized, Double-Masked Vehicle Controlled VELOS-4 Trial Evaluating Tanfanercept for Treatment of Dry Eye Disease